BET-IN-23 (Compound 23) is a BD2-selective BET inhibitor with an IC50 of 2.9 nM. It exhibits anticancer activity by significantly inhibiting the proliferation of acute myeloid leukemia (AML) cell lines, inducing G0/G1 arrest, and apoptosis in vitro [1].
Molecular Weight:
523.6
CAS Number:
[2953287-57-3]
Formula:
C29H34FN3O5
Target:
Apoptosis|||Epigenetic Reader Domain
T85847
* VAT and and shipping costs not included. Errors and price changes excepted